AKLI Stock Summary and Trading Ideas (Akili | NASDAQ:AKLI)

Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.

Akili trades on the NASDAQ stock market under the symbol AKLI.

As of May 23, 2024, AKLI stock price declined to $0.41 with 91,143 million shares trading.

AKLI has a beta of 1.76, meaning it tends to be more sensitive to market movements. AKLI has a correlation of 0.04 to the broad based SPY ETF.

AKLI has a market cap of $32.27 million. This is considered a Sub-Micro Cap stock.

Last quarter Akili reported $383,000 in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-407,000 and exceeded earnings estimates by $.02.

The top ETF exchange traded funds that AKLI belongs to (by Net Assets): IWC, VXF, VTI.

AKLI has underperformed the market in the last year with a price return of -68.5% while the SPY ETF gained +27.2%. However, in the short term, AKLI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +84.9% vs +4.0% return in SPY. But in the last 2 weeks, AKLI shares have been beat by the market, returning +1.0% compared to an SPY return of +1.7%.

AKLI support price is $.39 and resistance is $.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKLI stock will trade within this expected range on the day.